Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 7, 2014; 20(37): 13512-13520
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13512
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13512
Table 4 Analysis of the immunosuppressant drugs used at international islet transplantation research centers
| Immunosuppressant | Number of centers using theimmunosuppressant(based on data from the literature) |
| CsA | 6 |
| MMF | 3 |
| CTLA4 Ig | 4 |
| CD40 Ig | 2 |
| NF-kB Inhibitor (DHMEQ) | 1 |
| Anti-CD154 mAb (MR1) | 2 |
| Tritiated thymidine | 1 |
| Tacrolimus | 1 |
| Blockade of CD28:B7 | 1 |
| Tautomycetin | 1 |
| Protein Kinase C Inhibitor (AEB-071) | 1 |
| Monoclonal antibody anti-BIP-10 | 1 |
| Rapamycin+FK506+anti–IL- | |
| 2Ra chain mAbs, n31 and rapamycin+IL-10; n29 | 1 |
| LTβ R-Ig | 1 |
| LTR mAb | 1 |
| ROS-A | 1 |
| AR-C117977 | 1 |
| B7-H4 and Ad-LacZ | 1 |
| Anti-rat antilymphocyte serum | 1 |
| No immunosuppression | 9 |
- Citation: Iuamoto LR, Meyer A, Chaib E, D’Albuquerque LAC. Review of experimental attempts of islet allotransplantation in rodents: Parameters involved and viability of the procedure. World J Gastroenterol 2014; 20(37): 13512-13520
- URL: https://www.wjgnet.com/1007-9327/full/v20/i37/13512.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i37.13512